Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Voyager Therapeutics (VYGR) Asset Utilization Ratio (2016 - 2025)

Voyager Therapeutics (VYGR) has disclosed Asset Utilization Ratio for 11 consecutive years, with 0.15 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 23.48% to 0.15 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.15 through Dec 2025, down 23.48% year-over-year, with the annual reading at 0.13 for FY2025, 41.79% down from the prior year.
  • Asset Utilization Ratio hit 0.15 in Q4 2025 for Voyager Therapeutics, up from 0.1 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.77 in Q4 2023 to a low of 0.08 in Q3 2021.
  • Historically, Asset Utilization Ratio has averaged 0.34 across 5 years, with a median of 0.26 in 2022.
  • Biggest five-year swings in Asset Utilization Ratio: tumbled 88.4% in 2021 and later soared 409.54% in 2023.
  • Year by year, Asset Utilization Ratio stood at 0.2 in 2021, then grew by 21.1% to 0.24 in 2022, then soared by 223.48% to 0.77 in 2023, then crashed by 74.76% to 0.2 in 2024, then decreased by 23.48% to 0.15 in 2025.
  • Business Quant data shows Asset Utilization Ratio for VYGR at 0.15 in Q4 2025, 0.1 in Q3 2025, and 0.13 in Q2 2025.